FORM 6-K
 
 
SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549
 
 
Report of Foreign Issuer
 
 
Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934
 
 
 
For period ending 04 May 2017
 
GlaxoSmithKline plc
(Name of registrant)

 
 
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)

 
 
 
Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F

 
 
 
Form 20-F x     Form 40-F

 
--

 
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.

 
 
 
Yes      No x
 
 
 
 
 GlaxoSmithKline plc
 
 Result of AGM
 
GlaxoSmithKline plc ('GSK') announces that at its Annual General Meeting ('AGM') today, all resolutions were passed by shareholders. The full text of each resolution is contained in the 2017 Notice of AGM, which is available on the GSK website, www.gsk.com. 
 
GSK AGM Poll Results
 
The following table shows the total number of votes cast for each resolution:
 
 
Resolution
Total votes
for*
%
Total votes
against
%
Total votes
cast
Votes
withheld**
1
To receive and adopt the 2016 Annual Report
3,554,183,464
97.22
101,455,389
2.78
3,655,638,853
4,387,214
2
Approve the Annual report on remuneration
3,463,239,643
96.39
129,558,994
3.61
3,592,798,637
67,227,431
3
Approve the Remuneration policy
3,422,452,218
95.23
171,330,252
4.77
3,593,782,470
66,243,598
4
Election of Emma Walmsley
3,634,697,039
99.38
22,652,327
0.62
3,657,349,366
2,676,702
5
Election of Dr Vivienne Cox
3,585,205,455
98.03
72,167,674
1.97
3,657,373,129
2,653,239
6
To elect Dr Patrick Vallance
3,629,796,597
99.25
27,494,401
0.75
3,657,290,998
2,735,337
7
Re-election of Sir Philip Hampton
3,628,585,104
99.22
28,393,827
0.78
3,656,978,931
3,047,437
8
Re-election of Professor Sir Roy Anderson
3,625,292,635
99.12
32,058,752
0.88
3,657,351,387
2,674,980
9
Re-election of Vindi Banga
3,581,285,228
97.92
76,000,048
2.08
3,657,285,276
2,741,092
10
Re-election of Simon Dingemans
3,518,149,283
96.20
139,147,225
3.80
3,657,296,508
2,729,860
11
Re-election of Lynn Elsenhans
3,638,701,603
99.49
18,607,222
0.51
3,657,308,825
2,710,187
12
Re-election of Dr Jesse Goodman
3,639,142,174
99.50
18,139,405
0.50
3,657,281,579
2,714,188
13
Re-election of Judy Lewent
3,510,396,677
95.98
146,948,919
4.02
3,657,345,596
2,680,772
14
Re-election of Urs Rohner
3,575,150,146
97.76
82,080,983
2.24
3,657,231,129
2,795,239
15
Re-appointment of auditors
3,589,897,930
98.70
47,405,837
1.30
3,637,303,767
22,722,600
16
Remuneration of auditors
3,634,255,503
99.37
23,089,499
0.63
3,657,345,002
2,674,361
17
Authority for the company to make donations to political organisations and incur political expenditure
3,590,068,747
98.21
65,556,654
1.79
3,655,625,401
4,400,967
18
Authority to allot shares
3,545,752,292
96.96
111,083,355
3.04
3,656,835,647
3,190,721
19
Disapplication of pre-emption rights - general power***
3,579,962,643
97.94
75,432,563
2.06
3,655,395,206
4,624,157
20
Disapplication of pre-emption rights - in connection with an acquisition or specified capital investment***
3,395,638,484
92.96
257,114,976
7.04
3,652,753,460
7,265,904
21
Authority for the company to purchase its own shares***
3,607,672,499
98.68
48,202,613
1.32
3,655,875,112
4,151,256
22
Exemption from statement of senior statutory auditor's name
3,629,354,814
99.28
26,480,369
0.72
3,655,835,183
4,198,037
23
Authorise reduced notice of a general meeting other than an AGM***
3,407,170,884
93.19
248,934,681
6.81
3,656,105,565
3,920,802
24
Approve the GlaxoSmithKline 2017 Performance Share Plan
3,515,643,781
96.16
140,281,237
3.84
3,655,925,018
4,101,350
25
Approve the 2017 GlaxoSmithKline Deferred Annual Bonus Plan
3,579,310,888
97.97
74,224,589
2.03
3,653,535,477
6,490,891
 
Notes:
 
*
Includes discretionary votes.
**
A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.
***
 
Indicates Special Resolutions requiring a 75% majority.
 
 
 
The following table provides further relevant information:
 
 
 
 
 
GSK's
Seventeenth
AGM
(2017)
 
GSK's
Sixteen AGM
(2016)
 
Issued share capital (excluding Treasury Shares)
4,917,502,476
4,871,555,095
Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares)
74.43%
76.15%
Total shareholder population
116,502
132,85
Total number of proxies lodged
7,336
8,020
% of shareholders who lodged proxies
6.30%
6.03%
Number of shareholders, corporate representatives and proxies who attended the AGM
435
448
 
V A Whyte
Company Secretary
4 May 2017
 
These results will shortly be available on the company's website at www.gsk.com.
 
 
 
GSK enquiries:
 
 
 
 
UK Media enquiries:
David Mawdsley
+44 (0) 20 8047 5502
(London)
 
Simon Steel
+44 (0) 20 8047 5502
(London)
 
 
 
 
US Media enquiries:
Sarah Alspach
+1 202 715 1048
(Washington)
 
Sarah Spencer
+1 215 751 3335
(Philadelphia)
 
 
 
 
Analyst/Investor enquiries:
Sarah Elton-Farr
+44 (0) 20 8047 5194
(London)
 
Gary Davies
+44 (0) 20 8047 5503
(London)
 
James Dodwell
+44 (0) 20 8047 2406
(London)
 
Sarah Webster
+44 (0) 20 8047 0246
(London)
 
Tom Curry
+1 215 751 5419
(Philadelphia)
 
Jeff McLaughlin
+1 215 751 7002
(Philadelphia)
 
 
 
 
 
 
 
 
 
 
 
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

 
 
GlaxoSmithKline plc
 
(Registrant)
 
 
Date: May 04, 2017 
 
 
 
 
By: VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GlaxoSmithKline plc